In 2023, James Kastenmayer earned $419.05K in total compensation at Spyre Therapeutics, Inc., including $272.85K salary and $141.00K bonus. Led Spyre Therapeutics, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for James Kastenmayer, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$419.05K
Salary
$272.85K
Bonus
$141.00K
Other
$5.20K
Salary
$272.85KBoard Justification
Under this philosophy, compensation positioning is used to attract and retain key employees for the Company’s continued success and growth. While market data is helpful to the Compensation Committee in setting compensation framework and guiding decisions, other factors such as general market practices, Company strategy, tenure, performance and criticality are also considered. The compensation philosophy serves as the foundation to reinforce the Company’s business strategy and desired culture, while balancing internal and external alignment.
Bonus
$141.00KBoard Justification
Discretionary annual bonus
Other Compensation
$5.20KBoard Justification
Matching contributions under our 401(k) plan made during 2023
Restricted Stock
Board Justification
N/A
Performance Metrics
N/A
James Kastenmayer
Ex-CEO of Spyre Therapeutics, Inc.
Education
J.D. from Georgetown University Law Center, Ph.D. in biochemistry and cell & molecular biology from Michigan State University, B.A. in biology from the University of Virginia.
Field of Expertise
Legal & Compliance - Law
Sector of Economy
Healthcare
CEO of Spyre Therapeutics, Inc. for
1 year 1 month (Aug 2022 - Oct 2023)
Previous Experience
General Counsel at Viela Bio, roles at AstraZeneca PLC, IP counsel at MedImmune, LLC.
Other Spyre Therapeutics, Inc. CEOs
Holdings
Track James Kastenmayer's stock holdings and portfolio value over time.
Insider Trading
James Kastenmayer's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare James Kastenmayer with competitor CEOs and industry peers.